Department of Orthopedics, Hvidovre Hospital, Hvidovre 2650, Denmark.
Toxins (Basel). 2018 Apr 19;10(4):162. doi: 10.3390/toxins10040162.
Experiencing pain is the greatest contributor to a reduced quality of life in children with cerebral palsy (CP). The presence of pain is quite common (~60%) and increases with age. This leads to missed school days, less participation, and reduced ambulation. Despite these alarming consequences, strategies to relieve the pain are absent and poorly studied. Moreover, it is difficult to evaluate pain in this group of children, especially in cases of children with cognitive deficits, and tools for pain evaluation are often inadequate. Botulinum toxin has been shown to alleviate pain in a variety of disorders and could potentially have an analgesic effect in children with CP as well. Even though most of the studies presented here show promising results, many also have limitations in their methodology as it is unlikely to capture all dimensions of pain in this heterogeneous group using only one assessment tool. In this review, we present a new way of examining the analgesic effect of botulinum toxin in children with CP using a variety of pain scores.
在脑瘫(CP)儿童中,疼痛是降低生活质量的最大因素。疼痛的存在很常见(约 60%),并随着年龄的增长而增加。这导致缺课、参与度降低和行动能力下降。尽管存在这些令人担忧的后果,但缓解疼痛的策略仍然缺乏,研究也很少。此外,评估这群儿童的疼痛非常困难,尤其是在认知功能缺陷的儿童中,而且疼痛评估工具往往不够充分。肉毒毒素已被证明可以缓解多种疾病的疼痛,并且在 CP 儿童中也可能具有镇痛作用。尽管这里呈现的大多数研究都显示出有希望的结果,但它们的方法学也存在许多限制,因为仅使用一种评估工具不太可能捕捉到这个异质群体的所有疼痛维度。在这篇综述中,我们提出了一种使用各种疼痛评分来检查肉毒毒素在 CP 儿童中的镇痛效果的新方法。